Chapter 23. Radiolabeled Peptides for Tumor Imaging

  1. Michael J. Welch2 and
  2. Carol S. Redvanly3
  1. Linda C. Knight

Published Online: 28 JAN 2005

DOI: 10.1002/0470846380.ch23

Handbook of Radiopharmaceuticals: Radiochemistry and Applications

Handbook of Radiopharmaceuticals: Radiochemistry and Applications

How to Cite

Knight, L. C. (2002) Radiolabeled Peptides for Tumor Imaging, in Handbook of Radiopharmaceuticals: Radiochemistry and Applications (eds M. J. Welch and C. S. Redvanly), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470846380.ch23

Editor Information

  1. 2

    Washington University School of Medicine, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Boulevard, Campus Box 8225, St. Louis, MO, USA

  2. 3

    Department of Chemistry, Brookhaven National Laboratory Associated Universities Ltd, Upton, New York, USA

Author Information

  1. Nuclear Medicine Division, Diagnostic Imaging Department, Temple University School of Medicine, 3401 N. Broad Street, Philadelphia, PA, USA

Publication History

  1. Published Online: 28 JAN 2005
  2. Published Print: 27 NOV 2002

ISBN Information

Print ISBN: 9780471495604

Online ISBN: 9780470846384

SEARCH

Keywords:

  • radiolabeled peptides;
  • vasoactive intestinal peptide (VIP);
  • cancer imaging

Summary

This chapter contains sections titled:

  • Introduction

  • Neuropeptides

  • Somatostatin and Octreotide

  • 123I-labeled Somatostatin Analogues

  • 99MTC Labeled Octreotide Analogues

  • Labeling Octreotide for PET

  • Other Somatostatin Analogues

  • Glycated Octreotide Analogues

  • Markers of Tumor Angiogenesis

  • Integrins

  • Peptide Ligands for Integrin αvβ3

  • Summary

  • Acknowledgements

  • Glossary

  • References